Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS).

Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS).
复制标题

长效丁丙诺啡与纳曲酮阿片类药物治疗CJS受累成人(EXIT-CJS)。

DOI:
10.1016/j.jsat.2021.108389
复制
发表时间:
2021-09
影响因子:
3.9
通讯作者:
Lee JD
Lee JD
中科院分区:
医学2区
文献类型:
--
作者:
Waddell EN;Springer SA;Marsch LA;Farabee D;Schwartz RP;Nyaku A;Reeves R;Goldfeld K;McDonald RD;Malone M;Cheng A;Saunders EC;Monico L;Gryczynski J;Bell K;Harding K;Violette S;Groblewski T;Martin W;Talon K;Beckwith N;Suchocki A;Torralva R;Wisdom JP;Lee JD

文献摘要

参考文献

被引文献

相似文献

ext -CJS (N = 1005)多站点开放标签随机对照试验将比较缓释丁丙诺啡(XR-B)与缓释纳曲酮(XR-NTX)在美国六个地区(新泽西州、纽约市、特拉华州、俄勒冈州、康涅狄格州和新罕布什尔州)涉及刑事司法系统(CJS)的成年人中治疗阿片类药物使用障碍(OUD)的保留率和有效性。通过实用的非劣效性设计,本研究假设XR-B (n = 335)在保留研究药物治疗(主要结果)、自我报告的阿片类药物使用、阿片类药物阳性尿样、阿片类药物过量事件和CJS再犯方面不逊于XR-NTX (n = 335)。此外,不符合条件或对RCT感兴趣的OUD患者将被招募到强化治疗常规组(n = 335),以准实验观察队列检查常规护理结果。
The EXIT-CJS (N = 1005) multisite open-label randomized controlled trial will compare retention and effectiveness of extended-release buprenorphine (XR-B) vs. extended-release naltrexone (XR-NTX) to treat opioid use disorder (OUD) among criminal justice system (CJS)-involved adults in six U.S. locales (New Jersey, New York City, Delaware, Oregon, Connecticut, and New Hampshire). With a pragmatic, noninferiority design, this study hypothesizes that XR-B (n = 335) will be noninferior to XR-NTX (n = 335) in retention-in-study-medication treatment (the primary outcome), self-reported opioid use, opioid-positive urine samples, opioid overdose events, and CJS recidivism. In addition, persons with OUD not eligible or interested in the RCT will be recruited into an enhanced treatment as usual arm (n = 335) to examine usual care outcomes in a quasi-experimental observational cohort.
DOI: 10.1080/08897077.2011.611460
发表时间: 2012
期刊: Substance abuse
影响因子: 3.5
作者:
Friedmann PD;Hoskinson R;Gordon M;Schwartz R;Kinlock T;Knight K;Flynn PM;Welsh WN;Stein LA;Sacks S;O'Connell DJ;Knudsen HK;Shafer MS;Hall E;Frisman LK;Mat Working Group Of CJ-Dats
通讯作者: Mat Working Group Of CJ-Dats
DOI: 10.1007/s11524-010-9438-4
发表时间: 2010-07
影响因子: 6.6
作者:
Springer, Sandra Ann;Chen, Shu;Altice, Frederick L.
通讯作者: Altice, Frederick L.
DOI: 10.1016/j.jsat.2013.02.005
发表时间: 2013-08
影响因子: 3.9
作者:
Zaller N;McKenzie M;Friedmann PD;Green TC;McGowan S;Rich JD
通讯作者: Rich JD
DOI: 10.1001/jamapsychiatry.2017.3206
发表时间: 2017-12-01
期刊: JAMA PSYCHIATRY
影响因子: 25.8
作者:
Tanum, Lars;Solli, Kristin Klemmetsby;Kunoe, Nikolaj
通讯作者: Kunoe, Nikolaj
DOI: 10.1016/j.drugalcdep.2015.09.001
发表时间: 2015-11-01
影响因子: 4.2
作者:
Vocci, Frank J.;Schwartz, Robert P.;Jaffe, Jerome H.
通讯作者: Jaffe, Jerome H.